A clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes. Obesity and diabetes are the two most prevalent diseases in the world, affecting more than 750 million people, and are associated with severe health complications, including cardiovascular disease (CVD), chronic kidney disease (CKD), as well as an increased risk of death, among others.
Lead Underwriter
BofA Securities, Inc, Guggenheim Securities, LLC, J.P. Morgan Securities LLC, Piper Sandler & Co
